1. Home
  2. RVMD vs WF Comparison

RVMD vs WF Comparison

Compare RVMD & WF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • WF
  • Stock Information
  • Founded
  • RVMD 2014
  • WF 1899
  • Country
  • RVMD United States
  • WF South Korea
  • Employees
  • RVMD N/A
  • WF N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • WF Commercial Banks
  • Sector
  • RVMD Health Care
  • WF Finance
  • Exchange
  • RVMD Nasdaq
  • WF Nasdaq
  • Market Cap
  • RVMD 7.4B
  • WF 8.7B
  • IPO Year
  • RVMD 2020
  • WF N/A
  • Fundamental
  • Price
  • RVMD $39.40
  • WF $41.66
  • Analyst Decision
  • RVMD Strong Buy
  • WF
  • Analyst Count
  • RVMD 12
  • WF 0
  • Target Price
  • RVMD $68.67
  • WF N/A
  • AVG Volume (30 Days)
  • RVMD 2.0M
  • WF 50.1K
  • Earning Date
  • RVMD 05-07-2025
  • WF 07-24-2025
  • Dividend Yield
  • RVMD N/A
  • WF 4.42%
  • EPS Growth
  • RVMD N/A
  • WF 19.20
  • EPS
  • RVMD N/A
  • WF 2.49
  • Revenue
  • RVMD N/A
  • WF $7,562,040,413.00
  • Revenue This Year
  • RVMD N/A
  • WF N/A
  • Revenue Next Year
  • RVMD $241.39
  • WF $2.09
  • P/E Ratio
  • RVMD N/A
  • WF $5.56
  • Revenue Growth
  • RVMD N/A
  • WF 14.16
  • 52 Week Low
  • RVMD $29.17
  • WF $29.44
  • 52 Week High
  • RVMD $62.40
  • WF $42.80
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 51.81
  • WF 75.09
  • Support Level
  • RVMD $36.53
  • WF $38.58
  • Resistance Level
  • RVMD $40.00
  • WF $42.67
  • Average True Range (ATR)
  • RVMD 1.80
  • WF 1.21
  • MACD
  • RVMD -0.21
  • WF 0.19
  • Stochastic Oscillator
  • RVMD 47.28
  • WF 78.89

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About WF Woori Financial Group Inc. (each representing three (3) shares of)

Woori Financial Group Inc is a banking and financial services holdings company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. Its operating segments include Banking, Credit card, capital, Investment banking, and others.

Share on Social Networks: